Dagens.com on MSN
New study challenges Ozempic "no effort" myth
New findings are challenging assumptions about weight-loss injections and lifestyle habits.
Supermodel Kim Alexis says body positivity can become unhealthy, urging women to move beyond self-acceptance toward actively ...
Derek Chisora vs. Deontay Wilder in the main event on Saturday, Apr. 4: Here's how to find, livestream and watch the PPV ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...
LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, ...
One Michigan man's journey from restaurant owner to diabetes patient highlights epidemic affecting 13.5% of adults, with disparities hitting minority populations hardest and 115 million in prediabetic ...
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) March 20 (Reuters) - Taking GLP-1 drugs for diabetes has been shown to lower ...
MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...
This study is Pew Research Center’s latest effort to explore the landscape of teens and technology today. It focuses on artificial intelligence – from how teens use chatbots to how they think about AI ...
The cost of GLP-1 medications varies widely, ranging from around $199 to over $1,500. Insurance coverage for GLP-1s is more ...
Part 4 of the TED Radio Hour episode What can you control in this chaotic world? What do you want out of life? Instead of ignoring daunting questions like this, designer Bill Burnett says we should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results